Autologous Stem Cell Transplantation in Multiple Myeloma

Phyllis McKiernan
Published: Tuesday, Feb 20, 2018



Phyllis McKiernan, a nurse practitioner at John Theurer Cancer Center, Hackensack Medical Center, discusses the outcomes of a study investigating autologous stem cell transplantation (ASCT) in elderly patients with multiple myeloma.

This study included 496 patients who underwent ASCT for multiple myeloma over a 10-year period. Of the 496 patients, 24 patients were over the age of 75.

McKiernan notes that elderly patients are typically considered to be those who are over the age of 65; however, many patients undergo transplantation at an even older age. Thus, investigators wanted to follow the patients who were over the age of 75 to determine what influenced the course of their transplantation and outcomes.

Investigators discovered that patients over the age of 75 who underwent transplant experienced no difference in overall survival and no difference in progression-free survival when compared with patients under the age of 75.
 


Phyllis McKiernan, a nurse practitioner at John Theurer Cancer Center, Hackensack Medical Center, discusses the outcomes of a study investigating autologous stem cell transplantation (ASCT) in elderly patients with multiple myeloma.

This study included 496 patients who underwent ASCT for multiple myeloma over a 10-year period. Of the 496 patients, 24 patients were over the age of 75.

McKiernan notes that elderly patients are typically considered to be those who are over the age of 65; however, many patients undergo transplantation at an even older age. Thus, investigators wanted to follow the patients who were over the age of 75 to determine what influenced the course of their transplantation and outcomes.

Investigators discovered that patients over the age of 75 who underwent transplant experienced no difference in overall survival and no difference in progression-free survival when compared with patients under the age of 75.
 



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Personalized Sequencing in Castration-Resistant Prostate Cancer: Bridging the Latest Evidence to the Bedside in Clinical ManagementAug 25, 20181.5
Community Practice Connections™: Medical Crossfire®: Translating Lessons Learned with PARP Inhibition to the Treatment of Breast Cancer—Expert Exchanges on Novel Strategies to Personalize CareAug 29, 20181.5
Publication Bottom Border
Border Publication
x